Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,622 | -31,709 | -12,892 | -5,149 | -46,519 |
| Depreciation Amortization | 1,440 | 270 | 184 | 107 | 221 |
| Income taxes - deferred | -2,003 | N/A | N/A | N/A | N/A |
| Accounts receivable | 818 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 553 | 2,321 | 1,362 | -131 | 283 |
| Other Working Capital | -8,422 | 6,430 | 3,810 | 218 | -345 |
| Other Operating Activity | 33,388 | 8,138 | 330 | 1,467 | 32,772 |
| Operating Cash Flow | $-55,848 | $-14,550 | $-7,206 | $-3,488 | $-13,588 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -647 | N/A | -400 | -22 | -758 |
| Purchase Of Investment | -16,590 | -522 | N/A | N/A | N/A |
| Sale Of Investment | 52,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 74,909 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $109,672 | $-522 | $-400 | $-22 | $-758 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -47 | -31 | -31 | -13 | -79 |
| Common Stock Issued | 109,860 | 1 | 1 | 1 | 17 |
| Other Financing Activity | 14,479 | 14,479 | 14,479 | 14,479 | 25,748 |
| Financing Cash Flow | $124,292 | $14,449 | $14,449 | $14,467 | $25,686 |
| Exchange Rate Effect | 27 | -67 | -152 | -191 | 17 |
| Beginning Cash Position | 11,357 | 11,357 | 11,357 | 11,357 | N/A |
| End Cash Position | 189,500 | 10,667 | 18,048 | 22,123 | 11,357 |
| Net Cash Flow | $178,143 | $-690 | $6,691 | $10,766 | $11,357 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,848 | -14,550 | -7,206 | -3,488 | -13,588 |
| Capital Expenditure | -797 | N/A | -400 | -22 | -758 |
| Free Cash Flow | -56,645 | -14,550 | -7,606 | -3,510 | -14,346 |